83 results on '"Lämmle B"'
Search Results
2. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
3. The Von Willebrand factor multimer ratio and inflammatory markers in autoimmune thrombotic thrombocytopenic purpura
4. Conclusion from 50 years of reports on prekallikrein or high-molecular-weight kininogen deficiency
5. Neonatal exchange transfusion: hereditary thrombotic thrombocytopenic purpura (hTTP) should be in the differential diagnosis
6. Association between thyroid dysfunction and venous thromboembolism in the elderly: a prospective cohort study
7. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
8. Impaired DNase1‐mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies
9. In vitrorescue of FGAdeletion by lentiviral transduction of an afibrinogenemic patient's hepatocytes
10. Late onset and pregnancy-induced congenital thrombotic thrombocytopenic purpura
11. Bilateral periorbital ecchymoses
12. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism
13. Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry
14. Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism
15. Variability of anti‐PF4/heparin antibody results obtained by the rapid testing system ID‐H/PF4‐PaGIA
16. Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13)
17. ADAMTS‐13, von Willebrand factor and related parameters in severe sepsis and septic shock
18. Thrombotic thrombocytopenic purpura
19. The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency
20. The von Willebrand Factor-Cleaving Protease (ADAMTS-13) and the Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP)
21. Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods
22. Accuracy of d-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study
23. Acquired von Willebrand syndrome in myeloproliferative disorder
24. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera
25. Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency
26. Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10)
27. High Molecular Weight Kininogen Is Cleaved by FXIa at Three Sites: Arg409-Arg410, Lys502-Thr503 and Lys325-Lys326
28. Reevaluation of the Incidence of Thromboembolic Complications in Congenital Factor XII Deficiency
29. Factor XII, Plasma Prekallikrein, α2-Macroglobulin and C1-Inhibitor Levels in Renal Allograft Recipients During Immunosuppression with Cyclosporin A – Sequential Measurements over Four Months in 17 Patients
30. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
31. Functional Characterization of a Variant Prekallikrein (PK Zürich)
32. Is Plasminogen Deficiency a Thrombotic Risk Factor ? – A Study on 23 Thrombophilic Patients and their Family Members
33. Binding of α-thrombin to fibrin depends on the quality of the fibrin network
34. Protein S und venöse Thrombophilie
35. Therapie der akuten tiefen Beinvenenthrombose mit niedermolekularen Heparinen
36. Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
37. Heparin Cofactor II: Purification and Antibody Production
38. Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with Vasculopathy
39. Platelet Aggregation, β-Thromboglobulin and Platelet Factor 4 in Diabetes Mellitus and in Patients with Vasculopathy
40. Plasmin Inhibitors and Fibrinogen Breakdown During the Initial Phase of Thrombolytic Treatment - The Problem of the α2-Antiplasmin Determination
41. Different Assessment of Plasmin with Different Substrates
42. Monitoring of Oral Anticoagulation by an Amidolytic Factor X Assay
43. 1,25 (OH)2 Vitamin D3 in Osteoporosis - A Pilot Study
44. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
45. Autoactivation of human plasma prekallikrein.
46. Primärer Hyperparathyreoidismus — Semiquantitative Erfassung der Fibroosteoklasie und des Knochenumsatzes im Handröntgenbild
47. Chronic interstitial nephritis in Whipple's disease
48. A new tool to further explore the role of ADAMTS‐13 in health and disease
49. Measurement of ADAMTS‐13 activity in plasma by the FRETS‐VWF73 assay: comparison with other assay methods
50. Usefulness of the D‐dimer/fibrinogen ratio to predict deep venous thrombosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.